Phase
Condition
Soft Tissue Sarcoma
Sarcoma (Pediatric)
Sarcoma
Treatment
hypofractionation
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult patients (≥18 years of age)
Patients with primary or locally recurrent extremity or truncal soft tissue sarcoma
WHO/ECOG status ≤2
Exclusion
Exclusion Criteria:
History of prior local radiation therapy
Inability to tolerate treatment position for duration of simulation or treatment
Tumor originating in retroperitoneal location
Patients planned for systemic therapy including chemotherapy, targeted agents, andimmunotherapy
Co-existing malignancy or treated malignancy in the last 2 years expected to limitlife expectancy; does not include completely resected cutaneous basal cellcarcinoma, squamous cell carcinoma, in situ breast or cervical malignancies, orother pathologies at the discretion of the investigators.
Confirmed pregnancy.
Study Design
Connect with a study center
Sibley Memorial Hospital
Washington, District of Columbia 20016
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.